2BB score and signals
Trevi Therapeutics, Inc.’s current 2BB score is 13 out of 100, built from the signal categories below.
| Signal | Score | Reading |
|---|---|---|
| Activity | 12 | Very Low |
| Momentum | 50 | Stable |
| Quality | 60 | Strong |
Trevi Therapeutics, Inc. (TRVI) Stock Score & Signals
Trevi Therapeutics, Inc. (TRVI) trades on NASDAQ. It operates in the Health Care sector, Biotechnology industry. Its current 2BB score is 13 out of 100.
Company facts
| Headquarters | New Haven, Connecticut, United States |
| Founded | 2011 |
| Employees | 34 |
| 52-week range | $5.53 – $19.26 |
Recent earnings
| Report date | EPS actual | EPS estimate | Revenue actual | Revenue estimate |
|---|---|---|---|---|
| 2027-03-15 | — | -0.153 | — | $0.00 |
| 2026-11-11 | — | -0.1374 | — | $0.00 |
| 2026-08-06 | — | -0.1125 | — | $0.00 |
| 2026-05-06 | — | -0.1173 | — | $0.00 |